Clinical Trial Update: 131MIBG to Treat Malignant Pheochromocytoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating iobenguane I-131 (131I-MIBG) for malignant pheochromocytoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pheochromocytoma

Drugs mentioned

• Iobenguane I-131 (iobenguane I-131)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Pheochromocytoma | Phase 2 | Status: COMPLETED